Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Q2 Results Preview: Celgene, Amgen, Allergan And AbbVie

Jul 23 2018

• By Joseph Haas and Mandy Jackson

business documents accounting with calculator and magnifying glass. concept for financial

Related Content

Celgene's Partnered Pipeline Delivers Successes And Setbacks

Nov 21 2017

Celgene Admits It Screwed Up Otezla Estimates; Investors Lose Confidence

Oct 27 2017

Celgene IBD Pipeline In Question As Mongersen Crohn’s Disease Trial Ends

Oct 20 2017

Outcomes Claim May Help Amgen Make Case For PCSK9 Inhibitor Repatha

Dec 02 2017

Pfizer v. J&J Sets Stage For Biosimilar Showdown Over Exclusive Contracts

Sep 21 2017

Merck's Keytruda Keeps Nipping At Opdivo's Heels

May 01 2018

Severe Asthma Market Snapshot: A Competitive Therapy Area That Will Test Payers' Influence

May 23 2018

Amgen's Aimovig Aims To Capture As Many Migraine Patients As Possible With $6,900 Price

May 18 2018

Celgene Shares Good News On Ozanimod, Quietly Dumps Pricey GED-0301

May 06 2018

US Launch Of Sensipar Generics May Await Patent Case Even After FDA Approval

Mar 14 2018

Interchangeability Won’t Solve US Biosimilar Market’s Woes, FDA’s Gottlieb Says

Jul 19 2018

US Drug Pricing Reform: No More Medicare 'Gravy Train,' Azar Tells Pharma

May 18 2018

Amgen’s Challenge Over Sensipar Pediatric Exclusivity Moves To US Appeals Court

May 18 2018

Mylan's Fulphila Sets Up The US Market For The Next Biosimilar Showdown

Jul 12 2018

Attention Turns To Celgene's Other Pipeline Prospects Following Second Positive Luspatercept Read-Out

Jul 10 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Allergan's Abicipar Effective With Fewer Injections, But More Inflammation In AMD

Jul 20 2018

Roche, Bristol On The Defensive After Merck's Lung Cancer Wins At ASCO

Jun 06 2018

Mission Fulphila - Mylan-Biocon Biosimilar Neulasta Takes The Stage In US

Jun 05 2018

AstraZeneca Looks To Deliver On Its Promises In Oncology

Jun 26 2018

Specialists Rethink Lung Cancer Treatment Plans, With Eye On IO Biomarkers

Jun 14 2018

Gilead's CAR-T Therapy Yescarta Slowly Getting Off The Ground

Feb 07 2018

More Bad News: Celgene Reveals Refuse-To-File Letter For Ozanimod In MS

Feb 28 2018

AbbVie To Take Flight From Galapagos As PELICAN Flounders?

Jun 29 2018

Activist Investors Seek Action At Allergan, But Are They Aligned?

Jun 07 2018

SOLO-1 Lynparza Data In First-Line Ovarian Cancer Seen Boosting AstraZeneca's PARP Edge

Jun 27 2018

HCV Sales Drive AbbVie's Great Quarter, But Gains Won't Last

Apr 27 2018

Merck's Keytruda Enjoys Clean Sweep In Lung Cancer, At Bristol's Expense

Apr 17 2018

Related Companies

Bristol Myers Squibb Company

Pfizer Inc.

Amgen, Inc.

Viatris Inc.

Biocon, Ltd.

Novartis AG

AstraZeneca PLC

GSK plc

Teva Pharmaceutical Industries Ltd.

Bristol Myers Squibb Company

Merck & Co., Inc.

AbbVie Inc.

Johnson & Johnson

Vertex Pharmaceuticals Incorporated

Allergan plc

Roche Holding AG

Galapagos NV

Gilead Sciences, Inc.

Additional Topics

Sales & Earnings Biosimilars Companies Business Strategies Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window